TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells

Nature Medicine

Volumn 11, Issue 6, 2005, Pages 653-660

  Krutzik, Stephan R ^a   Tan, Belinda ^a   Li, Huiying ^b   Ochoa, Maria Teresa ^a   Liu, Philip T ^a   Sharfstein, Sarah E ^a   Graeber, Thomas G ^b   Sieling, Peter A ^a   Liu, Yong Jun ^c   Rea, Thomas H ^d   Bloom, Barry R ^e   Modlin, Robert L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD209 ANTIGEN; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; TOLL LIKE RECEPTOR;

ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE COURSE; HOST RESISTANCE; HUMAN; HUMAN CELL; LEPROSY; MACROPHAGE; MONOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; T LYMPHOCYTE ACTIVATION; TH1 CELL;

ANTIGENS, CD1; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; DENDRITIC CELLS; GENE EXPRESSION; HUMANS; IMMUNITY, NATURAL; LECTINS, C-TYPE; LEPROSY; LYMPHOCYTE ACTIVATION; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MONOCYTES; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS;

BACILLI;

EID: 20944442160     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1246     Document Type: Article

References (43)

1. Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J.M., & Hoffmann, J.A. The dorsoventral regulatory gene cassette spalzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86, 973-983 (1995).
2. Takeuchi, O., Hoshino, K., & Akira, S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to staphylococcus aureus infection. J. Immunol. 165, 5392-5395 (2000).
3. O'Brien, A.D. et al. Genetic control of susceptibility to Salmonella typhimunum in mice: role of the LPS gene. J. Immunol. 124, 20-24 (1980)
4. Alexopoulou, L. et al. Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in. Nat. Med. 8, 878-884 (2002).
5. Krutzik, S.R. et al. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat. Med. 9, 525-532 (2003).
6. Blander, J.M. & Medzhitov, R. Regulation of phagosome maturation by signals from toll-like receptors. Science 304, 1014-1018 (2004).
7. Doyle, S.E. et al. Toll-like receptors induce a phagocytic gene program through p38. J. Exp. Med. 199, 81-90 (2004).
8. Thoma-Uszynski, S. et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 291, 1544-1547 (2001).
9. Medzhitov, R., Preston-Hurlburt, P. & Janeway, C.A.J. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394-397 (1997).
10. Brightbill, H.D. et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285, 732-736 (1999).
11. Hertz, C.J. et al. Microbial lipopeptides stimulate dendritic cell maturation via TLR2. J. Immunol. 166, 2444-2450 (2000).
12. Porcelli, S.A. & Modlin, R. L. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 17, 297-329 (1999).
13. Beckman, E.M. et al. Recognition of a lipid antigen by CD1-restricted αβ+ T cells. Nature 372, 591-594 (1994).
14. Sieling, P.A. et al. CD1-restricted T cell recognition of microbial lipoglycans. Science 269, 227-230 (1995).
15. Moody, D.B. et al. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science 278, 283-285 (1997).
16. Engering, A. et al. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J. Immunol. 168, 2118-2125 (2002).
17. Geijtenbeek, T.B. et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100, 575-585 (2000).
18. Geijtenbeek, T.B. et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 197, 7-17 (2003).
19. Tailleux, L. et al. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J. Exp. Med. 197, 121-127 (2003).
20. Appelmelk, B.J. et al. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J. Immunol. 170, 1535-1539 (2003).
21. Cambi, A. et al. The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells. Eur. J. Immunol. 33, 532-538 (2003).
22. Colmenares, M., Puig-Kroger, A., Pello, O.M., Corbi, A.L. & Rivas, L. Dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-S)-grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes. J. Biol. Chem. 277, 35755-35759 (2002).
23. Wemambu, S.N.C., Turk, J.L., Waters, M.F.R. & Rees, R.J.W. Erythema nodosum leprosum: a clinical manifestation of the Arthus phenomenon. Lancet 2, 933-935 (1959).
24. Salgame, P. et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254, 279-282 (1991).
25. Yamamura, M. et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254, 277-279 (1991).
26. Yamamura, M. et al. Cytokine patterns of immunologically mediated tissue damage. J. Immunol. 149, 1470-1475 (1992).
27. Kadowaki, N. et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194, 863-869 (2001).
28. Graeber, T.G. & Eisenberg, D. Bioinformatic identification of potential autocrine signaling loops in cancers from gene expression profiles. Nat. Genet. 29, 295-300 (2001).
29. Ochoa, M.T. et al. T-cell release of granulysin contributes to host defense in leprosy. Nat. Med. 7, 174-179 (2001).
30. Soilleux, E.J. et al. Constitutive and induced, expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J. Leukoc. Biol. 71, 445-457 (2002).
31. Chehimi, J. et al. HIV-1 transmission and cytokine-induced expression of DC-SIGN in human monocyte-derived macrophages. J. Leukoc. Biol. 74, 757-763 (2003).
32. van Lent, P.L. et al. Expression of the dendritic cell-associated C-type lectin DC-SIGN by inflammatory matrix metalloproteinase-producing macrophages in rheumatoid arthritis synovium and interaction with intercellular adhesion molecule 3-positive T cells. Arthritis Rheum. 48, 360-369 (2003).
33. Giordano, D., Magaletti, D.M., Clark, E.A., & Beavo, J.A. Cyclic nucleotides promote monocyte differentiation toward a DC-SIGN+ (CD209) intermediate cell and impair differentiation into dendritic cells. J. Immunol. 171, 6421-6430 (2003).
34. Geijtenbeek, T.B. et al. DC-SIGN, a dendritic cell-specific HIV-1-brnding protein that enhances trans-infection of T cells. Cell 100, 587-597 (2000).
35. Relloso, M. et al. DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-beta, and anti-inflammatory agents. J. Immunol. 168, 2634-2643 (2002).
36. Judge, A.D., Zhang, X., Fujii, H., Surh, C.D. & Sprent, J. Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype CD8(+) T cells. J. Exp. Med. 196, 935-946 (2002).
37. Schluns, K.S., Williams, K., Ma, A., Zheng, X.X. & Lefrancois, L. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J. Immunol. 168, 4827-4831 (2002).
38. Pulendran, B. et al. Dendritic cells generated in the presence of GM-CSF plus IL-15 prime potent CD8+ Tc1 responses in vivo. Eur. J. Immunol. 34, 66-73 (2004).
39. Hirschfeld, M., Ma, Y., Weis, J.H., Vogel, S.N., & Weis, J.J. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J. Immunol. 165, 618-622 (2000).
40. Takeuchi, O. et al. Cutting edge: Preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway. J. Immunol. 164, 554-557 (2000).
41. Ridley, D.S. & Jopling, W.H. Classification of leprosy according to immunity. A five-group system. Int. J. Lepr. 34, 255-273 (1966).
42. Kim, J. et al. Determinants of T cell reactivity to the Mycobacterium leprae GroES homologue. J. Immunol. 159, 335-343 (1997).
43. Stenger, S. et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282, 121-125 (1998).